News

RenovoRx's Upcoming Participation at Vital Health Forum

RenovoRx's Upcoming Participation at Vital Health Forum

RenovoRx's Upcoming Participation at a Vital Health Forum

RenovoRx, Inc. (NASDAQ: RNXT), a pioneering life-sciences company, is poised to showcase its advancements at the Canaccord Genuity MedTech, Diagnostics & Digital Health & Services Forum. This is set to be a significant opportunity for the company to share insights on its innovative targeted oncology therapies. The forum will be held on November 20, where CEO Shaun Bagai will take the stage to discuss pivotal developments within the company.

Highlighting Innovations and Market Demand

Mr. Bagai aims to shed light on the commercialization progress of RenovoRx, focusing on the urgent clinical needs that RenovoCath addresses. With a growing demand for targeted drug delivery solutions, he will share how RenovoCath is becoming a standout product among both new and existing customers. Its patented technology is designed to deliver medications directly to tumors, minimizing systemic exposure and enhancing treatment efficacy.

Updates on Clinical Trials

At the upcoming forum, attendees will gain insights into the ongoing Phase III TIGeR-PaC clinical trial. This trial evaluates the efficacy of RenovoRx's unique intra-arterial drug-device combination, combining gemcitabine and RenovoCath in treating locally advanced pancreatic cancer. Mr. Bagai will also discuss a new post-marketing observational registry study aimed at assessing long-term safety and survival outcomes for patients receiving treatment through RenovoCath.

Details on the Forum

Event: Canaccord Genuity MedTech, Diagnostics & Digital Health & Services Forum
Date: November 20, 2025
Location: Westin NY Grand Central, New York

Connecting with RenovoRx

For investors interested in a more personalized dialogue, opportunity for one-on-one meetings with Mr. Bagai can be arranged through Canaccord Genuity representatives or via KCSA Strategic Communications.

About RenovoRx, Inc.

RenovoRx, Inc. is dedicated to developing innovative therapies that address significant oncological challenges. The company’s flagship product, RenovoCath, is an FDA-cleared local drug delivery device that targets unfulfilled medical needs in cancer treatment. With its Trans-Arterial Micro-Perfusion (TAMP™) platform, RenovoRx aims to deliver therapeutic agents closer to tumor sites, potentially reducing side effects and improving patient outcomes.

In addition to RenovoCath, the company is conducting the Phase III TIGeR-PaC trial, involving the IAG product candidate, which is poised to make significant contributions to oncology treatment protocols upon successful outcomes. With recent commercial orders for RenovoCath, including repeat purchases from several prominent cancer centers, RenovoRx is well-positioned to expand its market presence and enhance accessibility to its innovative therapies.

To learn more about RenovoRx and its offerings, visit their official website. Additionally, keep up with the latest updates on their social media platforms including Facebook, LinkedIn, and X.

Frequently Asked Questions

What is RenovoRx known for?

RenovoRx specializes in developing innovative targeted oncology therapies, significantly focusing on its patented RenovoCath device.

What will the forum focus on?

The forum will highlight RenovoRx’s commercialization progress, updates on clinical trials, and insights into market demands for targeted therapy solutions.

Where will the forum be held?

The Canaccord Genuity forum will take place at Westin NY Grand Central in New York.

How can investors connect with RenovoRx's CEO?

Investors can arrange one-on-one meetings with CEO Shaun Bagai through Canaccord Genuity representatives or KCSA Strategic Communications.

What is the significance of the Phase III clinical trial?

The Phase III clinical trial is critical as it evaluates the effectiveness of RenovoRx's innovative drug-device combination for treating pancreatic cancer.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Langford Chosen for Navy Mutual's 2026 Bolles Award

Updated Category News Views 225

Awarding a Military Financial Educator There's something profoundly rewarding when hard work and dedication get their due recognition. That's precisely what's happened for Lacey Langford, who’s just been awarded the Lieutenant Timothy Dix Bolles Excellency in Education Award by the Navy Mutual Aid Association, or simply Navy Mutual. This isn’t just some...

Continue Reading
iTLC Traffic Systems Expand Global Reach at APTA 2026

Updated Category News Views 108

APTA 2026: The Launchpad for Intelligent Traffic Control Forget the days of manual traffic chaos—by the sounds of it, smart intersections are ready to rule the roads. Today's chatter at APTA 2026 in Chicago was a whirlwind of ideas, all centered around how ICP DAS and Towards Buddha Co., Ltd. plan to shake up traffic management globally with their iTLC Intelligent...

Continue Reading
Lawsuit Hits San Ramon Medical: Wages, Breaks in Dispute

Updated Category News Views 106

Legal Storm Unleashes on San Ramon Regional In the world of legal entanglements, San Ramon Regional Medical Center found itself on the receiving end of the latest workforce fuss. Allegations flying from a class action lawsuit claim the center's brass didn't hold up their end of the California Labor Code, particularly in providing legit meal breaks and rest periods. Now,...

Continue Reading
UBCF Strikes Big in Times Square with New Billboards

Updated Category News Views 142

From the Shadows to the Spotlight Ever seen someone step up to the plate and knock it out of the park? That's what the United Breast Cancer Foundation (UBCF) is doing by plastering their mission right across Times Square. Talk about grabbing the bull by the horns, eh? With not one, but two billboards now gracing one of the globe's most iconic public spaces, they've...

Continue Reading
HK Boosts Oversight of Building Repairs Post-Blaze

Updated Category News Views 144

Big Moves After a Tragic Fire Hong Kong's revamping its approach to building maintenance and oversight, clearly in reaction to the horrific Wang Fuk Court blaze last year. That fire didn't just leave scars; it blew open glaring gaps in the city's oversight of building repairs. The government's now jumping into action by launching a raft of measures aimed at preventing...

Continue Reading
Rural AI Skills Gap Uncovered: Challenges and Solutions

Updated Category News Views 86

Rural Workers Face Distinct AI Challenges Ah, life in the countryside might sound serene, but when it comes to keeping up with AI, rural folks aren't sipping lemonade and waiting on a windfall. The newly unveiled paper from the University of Phoenix College of Doctoral Studies shines a floodlight on some hefty challenges facing rural communities—particularly around...

Continue Reading
Wulcea Pioneers Safety in Smart Heated Apparel

Updated Category News Views 71

Tech Behind the Warmth and Safety You ever turn on a heated jacket and wonder if it'll keep you safe as much as warm? That's the scene with Wulcea, a brand diving headfirst into the smart heated clothing market. People are waking up to what’s inside these technological coats, not just how they feel on a frosty walk. It’s the kind of scenario where safety meets...

Continue Reading
Gildan Investors on Edge Amid Allegations and Lawsuit

Updated Category News Views 111

Another Market Flash: Gildan Enters Rough Waters New Orleans has put a spotlight on Gildan Activewear, and not in a flattering way. We're talking about that precarious position corporations sometimes find themselves in when their dirty laundry gets aired out for the public to scrutinize. ClaimsFiler, the service urging shareholders to come forward, reminds folks that the...

Continue Reading
DKS Lawsuit Deadline: Investors Must Act by Nov 3, 2026

Updated Category News Views 78

Clock's Ticking for DICK'S Investors If you've got money tied up in DICK'S Sporting Goods—bought between September 8, 2025, and August 24, 2026—listen up. There's a class action lawsuit aiming to recover some of what might've slipped through your fingers. Come November 3, 2026, the door slams shut on your chance to get involved. What's the Beef? Apparently, DICK'S had...

Continue Reading
NABEP's Strategic Push: 41 Rigs to Bolster Output

Updated Category News Views 208

On The Ground: NABEP's Expanding Venezuelan Presence Think of oil production as a high-stakes poker game where each drill and rig is a well-placed bet. North American Blue Energy Partners (NABEP) is going all in on Venezuela, boosting their rig fleet and pushing production capacity to new heights. Set your sights on November when NABEP's in-country fleet will hit 41 rigs...

Continue Reading

Top 5 Most Recently Viewed Articles

Analog Devices Announces Impressive Q1 2025 Financial Success

Updated Category News Views 164

Strengths of Analog Devices in Q1 2025 Analog Devices, Inc. (NASDAQ: ADI), known for its semiconductor expertise, has shared its remarkable financial performance for the first quarter of FY2025. The company reported a revenue exceeding $2.4 billion, which reflects a solid sequential growth across its Industrial, Automotive, and Communications segments, alongside an...

Continue Reading
US Shipping Industry Takes Precautions Amid Strike Worries

Updated Category News Views 89

Concerns Grow Over Potential Dockworker Strikes Recent discussions among U.S. shippers indicate a growing concern regarding the potential for renewed strikes among dockworkers at East and Gulf Coast ports. These apprehensions stem from fears that the approximately 45,000 dockworkers could act if new contracts aren’t established before the looming deadline. Negotiations...

Continue Reading
Lisata Therapeutics Engages University of Cincinnati for Certepetide Research

Updated Category News Views 181

Lisata Therapeutics Collaborates with University of Cincinnati Lisata Therapeutics, Inc. (NASDAQ: LSTA), recognized for its commitment to developing innovative therapies, has embarked on a collaborative journey with the University of Cincinnati. This partnership aims to explore the capabilities of certepetide, an investigational cyclic peptide, specifically targeted for...

Continue Reading
OpenAI Executives Work to Retain Ilya Sutskever Amid Departures

Updated Category News Views 262

OpenAI Leadership Faces Uncertainty After Departures Executives at ChatGPT parent OpenAI have been navigating a wave of uncertainty within the company, particularly in light of recent departures of key team members, including co-founder Ilya Sutskever. This shake-up has sparked concerns about the future direction of the organization. Mira Murati's Exit Elevates Concerns...

Continue Reading
Hexaware Welcomes Eravi Gopan as New Leader for Tech Sector

Updated Category News Views 180

Hexaware's Strategic Leadership Appointment Hexaware Technologies, a renowned global IT solutions company, has taken a significant step forward by appointing Eravi Gopan as President and Global Head for High Tech, Products, and Platforms. This announcement reflects Hexaware's ambition to enhance its strategy and growth, as well as to drive client success across a variety...

Continue Reading